High Expression of Heterogeneous Nuclear Ribonucleoprotein A1 Facilitates Hepatocellular Carcinoma Growth

References

• Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6. doi:10.1038/s41572-020-00240-3
   PubMed Web of Science ®Google Scholar
• Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589–604. doi:10.1038/s41575-019-0186-y
   PubMed Web of Science ®Google Scholar
• Qiu Z, Li H, Zhang Z, et al. A pharmacogenomic landscape in human liver cancers. Cancer Cell. 2019;36(2):179–193.e11. doi:10.1016/j.ccell.2019.07.001
   PubMed Web of Science ®Google Scholar
• Craig AJ, von Felden J, Garcia-Lezana T, Sarcognato S, Villanueva A. Tumour evolution in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2020;17(3):139–152. doi:10.1038/s41575-019-0229-4
   PubMed Web of Science ®Google Scholar
• Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 2008;9:559. doi:10.1186/1471-2105-9-559
   PubMed Web of Science ®Google Scholar
• Li S, Han F, Qi N, et al. Determination of a six-gene prognostic model for cervical cancer based on WGCNA combined with LASSO and Cox-PH analysis. World J Surg Oncol. 2021;19(1):277. doi:10.1186/s12957-021-02384-2
   PubMed Web of Science ®Google Scholar
• Giulietti M, Occhipinti G, Principato G, Piva F. Weighted gene co-expression network analysis reveals key genes involved in pancreatic ductal adenocarcinoma development. Cell Oncol. 2016;39(4):379–388. doi:10.1007/s13402-016-0283-7
   PubMed Web of Science ®Google Scholar
• Ling B, Liao X, Huang Y, et al. Identification of prognostic markers of lung cancer through bioinformatics analysis and in vitro experiments. Int J Oncol. 2020;56(1):193–205. doi:10.3892/ijo.2019.4926
   PubMed Web of Science ®Google Scholar
• Dreyfuss G, Matunis MJ, Piñol-Roma S, Burd CG. hnRNP proteins and the biogenesis of mRNA. Annu Rev Biochem. 1993;62:289–321. doi:10.1146/annurev.bi.62.070193.001445
   PubMed Web of Science ®Google Scholar
• Dreyfuss G, Kim VN, Kataoka N. Messenger-RNA-binding proteins and the messages they carry. Nat Rev Mol Cell Biol. 2002;3(3):195–205. doi:10.1038/nrm760
   PubMed Web of Science ®Google Scholar
• Le KQ, Prabhakar BS, Hong WJ, Li LC. Alternative splicing as a biomarker and potential target for drug discovery. Acta Pharmacol Sin. 2015;36(10):1212–1218. doi:10.1038/aps.2015.43
   PubMed Web of Science ®Google Scholar
• Ule J, Blencowe BJ. Alternative splicing regulatory networks: functions, mechanisms, and evolution. Mol Cell. 2019;76(2):329–345. doi:10.1016/j.molcel.2019.09.017
   PubMed Web of Science ®Google Scholar
• Bonnal SC, López-Oreja I, Valcárcel J. Roles and mechanisms of alternative splicing in cancer - implications for care. Nat Rev Clin Oncol. 2020;17(8):457–474. doi:10.1038/s41571-020-0350-x
   PubMed Web of Science ®Google Scholar
• Geuens T, Bouhy D, Timmerman V. The hnRNP family: insights into their role in health and disease. Hum Genet. 2016;135(8):851–867. doi:10.1007/s00439-016-1683-5
   PubMed Web of Science ®Google Scholar
• Liu Y, Shi SL. The roles of hnRNP A2/B1 in RNA biology and disease. Wiley Interdiscip Rev RNA. 2021;12(2):e1612. doi:10.1002/wrna.1612
   PubMed Web of Science ®Google Scholar
• Han N, Li W, Zhang M. The function of the RNA-binding protein hnRNP in cancer metastasis. J Cancer Res Ther. 2013;9(Suppl):S129–S134. doi:10.4103/0973-1482.122506
   PubMedGoogle Scholar
• Roy R, Huang Y, Seckl MJ, Pardo OE. Emerging roles of hnRNPA1 in modulating malignant transformation. Wiley Interdiscip Rev RNA. 2017;8:6. doi:10.1002/wrna.1431
   Web of Science ®Google Scholar
• Chen M, Zhang J, Manley JL. Turning on a fuel switch of cancer: hnRNP proteins regulate alternative splicing of pyruvate kinase mRNA. Cancer Res. 2010;70(22):8977–8980. doi:10.1158/0008-5472.CAN-10-2513
   PubMed Web of Science ®Google Scholar
• Jia Q, Nie H, Yu P, et al. HNRNPA1-mediated 3’ UTR length changes of HN1 contributes to cancer- and senescence-associated phenotypes. Aging. 2019;11(13):4407–4437. doi:10.18632/aging.102060
   PubMedGoogle Scholar
• Jiang R, Su G, Chen X, et al. Esculetin inhibits endometrial cancer proliferation and promotes apoptosis via hnRNPA1 to downregulate BCLXL and XIAP. Cancer Lett. 2021;521:308–321. doi:10.1016/j.canlet.2021.08.039
   PubMed Web of Science ®Google Scholar
• Nishikawa T, Kuwano Y, Takahara Y, Nishida K, Rokutan K. HnRNPA1 interacts with G-quadruplex in the TRA2B promoter and stimulates its transcription in human colon cancer cells. Sci Rep. 2019;9(1):10276. doi:10.1038/s41598-019-46659-x
   PubMed Web of Science ®Google Scholar
• Zhu HE, Li T, Shi S, Chen DX, Chen W, Chen H. ESCO2 promotes lung adenocarcinoma progression by regulating hnRNPA1 acetylation. J Exp Clin Cancer Res. 2021;40(1):64. doi:10.1186/s13046-021-01858-1
   PubMed Web of Science ®Google Scholar
• Levengood JD, Tolbert BS. Idiosyncrasies of hnRNP A1-RNA recognition: can binding mode influence function. Semin Cell Dev Biol. 2019;86:150–161. doi:10.1016/j.semcdb.2018.04.001
   PubMed Web of Science ®Google Scholar
• Hay DC, Kemp GD, Dargemont C, Hay RT. Interaction between hnRNPA1 and IkappaBalpha is required for maximal activation of NF-kappaB-dependent transcription. Mol Cell Biol. 2001;21(10):3482–3490. doi:10.1128/MCB.21.10.3482-3490.2001
   PubMed Web of Science ®Google Scholar
• Fiset S, Chabot B. hnRNP A1 may interact simultaneously with telomeric DNA and the human telomerase RNA in vitro. Nucleic Acids Res. 2001;29(11):2268–2275. doi:10.1093/nar/29.11.2268
   PubMed Web of Science ®Google Scholar
• LaBranche H, Dupuis S, Ben-David Y, Bani MR, Wellinger RJ, Chabot B. Telomere elongation by hnRNP A1 and a derivative that interacts with telomeric repeats and telomerase. Nat Genet. 1998;19(2):199–202. doi:10.1038/575
   PubMed Web of Science ®Google Scholar
• Redon S, Zemp I, Lingner J. A three-state model for the regulation of telomerase by TERRA and hnRNPA1. Nucleic Acids Res. 2013;41(19):9117–9128. doi:10.1093/nar/gkt695
   PubMed Web of Science ®Google Scholar
• Lan Z, Yao X, Sun K, Li A, Liu S, Wang X. The interaction between lncRNA SNHG6 and hnRNPA1 contributes to the growth of colorectal cancer by enhancing aerobic glycolysis through the regulation of alternative splicing of PKM. Front Oncol. 2020;10:363. doi:10.3389/fonc.2020.00363
   PubMed Web of Science ®Google Scholar
• Durie D, Lewis SM, Liwak U, Kisilewicz M, Gorospe M, Holcik M. RNA-binding protein HuR mediates cytoprotection through stimulation of XIAP translation. Oncogene. 2011;30(12):1460–1469. doi:10.1038/onc.2010.527
   PubMed Web of Science ®Google Scholar
• Zheng J, Yue R, Yang R, et al. Visualization of zika virus infection via a light-initiated bio-orthogonal cycloaddition labeling strategy. Front Bioeng Biotech. 2022;10:940511. doi:10.3389/fbioe.2022.940511
   PubMed Web of Science ®Google Scholar
• Sun S, Deng P, Peng C, Ji H, Mao L, Peng L. Selenium-modified chitosan induces HepG2 cell apoptosis and differential protein analysis. Cancer Manag Res. 2022;28(14):3335–3345. doi:10.2147/CMAR.S382546
   Google Scholar
• Liu X, Zhou Y, Lou Y, Zhong H. Knockdown of HNRNPA1 inhibits lung adenocarcinoma cell proliferation through cell cycle arrest at G0/G1 phase. Gene. 2016;576(2 Pt 2):791–797. doi:10.1016/j.gene.2015.11.009
   PubMed Web of Science ®Google Scholar
• Park WC, Kim HR, Kang DB, et al. Comparative expression patterns and diagnostic efficacies of SR splicing factors and HNRNPA1 in gastric and colorectal cancer. BMC Cancer. 2016;16:358. doi:10.1186/s12885-016-2387-x
   PubMed Web of Science ®Google Scholar
• Zheng H, Chen C, Luo Y, et al. Tumor-derived exosomal BCYRN1 activates WNT5A/VEGF-C/VEGFR3 feedforward loop to drive lymphatic metastasis of bladder cancer. Clin Transl Med. 2021;11(7):e497. doi:10.1002/ctm2.497
   PubMed Web of Science ®Google Scholar
• Kim YJ, Kim BR, Ryu JS, et al. HNRNPA1, a splicing regulator, is an effective target protein for cervical cancer detection: comparison with conventional tumor markers. Int J Gynecol Cancer. 2017;27(2):326–331. doi:10.1097/IGC.0000000000000868
   PubMed Web of Science ®Google Scholar
• Ke R, Lv L, Li J, et al. Prognostic value of heterogeneous ribonucleoprotein A1 expression and inflammatory indicators for patients with surgically resected hepatocellular carcinoma: perspectives from a high occurrence area of hepatocellular carcinoma in China. Oncol Lett. 2018;16(3):3746–3756. doi:10.3892/ol.2018.9079
   PubMed Web of Science ®Google Scholar
• Ke RS, Zhang K, Lv LZ, et al. Prognostic value and oncogene function of heterogeneous nuclear ribonucleoprotein A1 overexpression in HBV-related hepatocellular carcinoma. Int J Biol Macromol. 2019;129:140–151. doi:10.1016/j.ijbiomac.2019.02.012
   PubMed Web of Science ®Google Scholar
• Li S, Wang W, Ding H, et al. Aptamer BC15 against heterogeneous nuclear ribonucleoprotein A1 has potential value in diagnosis and therapy of hepatocarcinoma. Nucleic Acid Ther. 2012;22(6):391–398. doi:10.1089/nat.2012.0363
   PubMed Web of Science ®Google Scholar
• Zhou ZJ, Dai Z, Zhou SL, et al., Overexpression of HnRNP A1 promotes tumor invasion through regulating CD44v6 and indicates poor prognosis for hepatocellular carcinoma. Int J Cancer. 2013;5:1080–1089. doi:10.1002/ijc.27742
   PubMed Web of Science ®Google Scholar
• Wen Z, Lian L, Ding H, et al. LncRNA ANCR promotes hepatocellular carcinoma metastasis through upregulating HNRNPA1 expression. RNA Biology. 2020;17(3):381–394. doi:10.1080/15476286.2019.1708547
   PubMed Web of Science ®Google Scholar
• Squires MS, Nixon PM, Cook SJ. Cell-cycle arrest by PD184352 requires inhibition of extracellular signal-regulated kinases (ERK) 1/2 but not ERK5/BMK1. Biochem J. 2002;366(Pt 2):673–680. doi:10.1042/bj20020372
   PubMedGoogle Scholar
• Berra E, Diaz-Meco MT, Moscat J. The activation of p38 and apoptosis by the inhibition of Erk is antagonized by the phosphoinositide 3-kinase/Akt pathway. J Biol Chem. 1998;273(17):10792–10797. doi:10.1074/jbc.273.17.10792
   PubMed Web of Science ®Google Scholar
• Tanimura S, Takeda K. ERK signalling as a regulator of cell motility. J Biochem. 2017;162(3):145–154. doi:10.1093/jb/mvx048
   PubMed Web of Science ®Google Scholar
• Kerr EM, Gaude E, Turrell FK, Frezza C, Martins CP. Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities. Nature. 2016;531(7592):110–113. doi:10.1038/nature16967
   PubMed Web of Science ®Google Scholar
• Saba-El-Leil MK, Frémin C, Meloche S. Redundancy in the world of MAP kinases: all for one. Front Cell Dev Biol. 2016;4:67. doi:10.3389/fcell.2016.00067
   PubMed Web of Science ®Google Scholar
• Maik-Rachline G, Hacohen-Lev-Ran A, Seger R. Nuclear ERK: mechanism of translocation, substrates, and role in cancer. Int J Mol Sci. 2019;20:5. doi:10.3390/ijms20051194
   Web of Science ®Google Scholar
• Barbosa R, Acevedo LA, Marmorstein R. The MEK/ERK network as a therapeutic target in human cancer. Mol Cancer Res. 2021;19(3):361–374. doi:10.1158/1541-7786.MCR-20-0687
   PubMed Web of Science ®Google Scholar
• Fey D, Matallanas D, Rauch J, Rukhlenko OS, Kholodenko BN. The complexities and versatility of the RAS-to-ERK signalling system in normal and cancer cells. Semin Cell Dev Biol. 2016;58:96–107. doi:10.1016/j.semcdb.2016.06.011
   PubMed Web of Science ®Google Scholar
• Zhang Z, Cui F, Cao C, Wang Q, Zou Q. Single-cell RNA analysis reveals the potential risk of organ-specific cell types vulnerable to SARS-CoV-2 infections. Comput Biol Med. 2022;140:105092. doi:10.1016/j.compbiomed.2021.105092
   PubMed Web of Science ®Google Scholar
• Tang W, Wan S, Yang Z, Teschendorff AE, Zou Q. Tumor origin detection with tissue-specific miRNA and DNA methylation markers. Bioinformatics. 2018;34(3):398–406. doi:10.1093/bioinformatics/btx622
   PubMed Web of Science ®Google Scholar
• Zou Y, Wu H, Guo X, et al. MK-FSVM-SVDD: a multiple kernel-based fuzzy SVM model for predicting DNA-binding proteins via support vector data description. Curr Bioinform. 2021;16(2):274–283. doi:10.2174/2212392XMTA3bMTYiy
   Web of Science ®Google Scholar
• Zhang Y, Huang W, Yuan Y, et al. Long non-coding RNA H19 promotes colorectal cancer metastasis via binding to hnRNPA2B1. J Exp Clin Cancer Res. 2020;39(1):141. doi:10.1186/s13046-020-01619-6
   PubMed Web of Science ®Google Scholar
• Chen LC, Liu HP, Li HP, et al. Thymidine phosphorylase mRNA stability and protein levels are increased through ERK-mediated cytoplasmic accumulation of hnRNPK in nasopharyngeal carcinoma cells. Oncogene. 2009;28(17):1904–1915. doi:10.1038/onc.2009.55
   PubMed Web of Science ®Google Scholar
• Sui X, Zhang R, Liu S, et al. RSL3 drives ferroptosis through GPX4 inactivation and ROS production in colorectal cancer. Front Pharmacol. 2018;9:1371. doi:10.3389/fphar.2018.01371
   PubMed Web of Science ®Google Scholar
• Zhao H, Ming T, Tang S, et al. Wnt signaling in colorectal cancer: pathogenic role and therapeutic target. Mol Cancer. 2022;21(1):144. doi:10.1186/s12943-022-01616-7
   PubMed Web of Science ®Google Scholar
• Datta A, Kim H, Lal M, et al. Manumycin A suppresses exosome biogenesis and secretion via targeted inhibition of Ras/Raf/ERK1/2 signaling and hnRNPH1 in castration-resistant prostate cancer cells. Cancer Lett. 2017;408:73–81. doi:10.1016/j.canlet.2017.08.020
   PubMed Web of Science ®Google Scholar
• Roth S, Khalaila I. The effect of O-GlcNAcylation on hnRNPA1 translocation and interaction with transportin1. Exp Cell Res. 2017;350(1):210–217. doi:10.1016/j.yexcr.2016.11.023
   PubMed Web of Science ®Google Scholar
• Abdrabou A, Wang Z. Regulation of the nuclear speckle localization and function of Rac1. FASEB J. 2021;35(2):e21235. doi:10.1096/fj.202001694R
   PubMed Web of Science ®Google Scholar
• Zhang H, Deng T, Liu R, et al. CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer. Mol Cancer. 2020;19(1):43. doi:10.1186/s12943-020-01168-8
   PubMed Web of Science ®Google Scholar